News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

US FDA Unveils Tighter Restrictions On Roche Holding AG's Acne Drug


10/19/2005 5:09:08 PM

Patients and doctors must register with manufacturers before using or prescribing Roche Holding AG's acne drug Accutane or its generic versions, U.S. regulators announced on Friday. The requirement is part of a plan to strengthen safeguards meant to keep pregnant women from taking Accutane, the Food and Drug Administration said in a statement. The drug can cause birth defects.

Read at Reuters
Read at FDA


comments powered by Disqus
Reuters
FDA
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES